Showing results (1-10 of 905) with videos related to
Sort By:
Pageof 91
American Heart Journal|June 24, 2010
Maximizing scientific knowledge from randomized clinical trialsFinn Gustafsson, Dan Atar, Bertram Pitt, et al.Circulation. Heart Failure|November 20, 2013
Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trialAmil M Shah, Sanjiv J Shah, Inder S Anand, et al.The American Journal of Cardiology|January 8, 2019
Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin + Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study)Thao Huynh, Brian J Harty, Brian Claggett, et al.European Heart Journal|July 7, 2007
Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approvalJeffrey S Borer, Hubert Pouleur, Eric Abadie, et al.European Journal of Heart Failure|November 10, 2021
Outpatient diuretic intensification as endpoint in heart failure with preserved ejection fraction trials: an analysis from TOPCATJoão Pedro Ferreira, Jiankang Liu, Brian L Claggett, et al.Current Atherosclerosis Reports|July 9, 2008
Medical therapy versus percutaneous coronary interventions for patients with stable and unstable coronary artery diseaseBertram PittHeart Failure Reviews|June 11, 2005
The role of aldosterone blockade in patients with heart failureBertram PittHeart Failure Reviews|October 15, 2011
The role of mineralocorticoid receptor antagonists (MRAs) in very old patients with heart failureBertram PittCurrent Heart Failure Reports|June 3, 2009
Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?Bertram PittJournal of Cardiac Failure|January 30, 2003
Do diuretics and aldosterone receptor antagonists improve ventricular remodeling?Bertram PittPageof 91